About AMI
Airway Management, Inc. (AMI) is committed to offering products that improve the health and quality of life for people who suffer from sleep-disordered breathing. Our goal is to support the laboratory technician and practitioner with high quality, minimally invasive therapy for snoring and sleep apnea.
In 1994, Dr. W. Keith Thornton, a third generation dentist in Dallas, Texas developed the
(TAP®), a medical anti-snoring and sleep apnea device. For over thirty years, Dr. Thornton had focused his dental practice on the treatment of temporomandibular disorders (TMD), and was a leader in the use of splint therapy for the treatment of TMD pain. Using his knowledge and background in TMD management, Dr. Thornton invented the most comfortable and effective device for snoring and sleep apnea.
The TAP® is a custom-made, patient-adjustable oral device that is worn while sleeping. The TAP®’s simple design coupled with its high compliance rate makes it the most effective anti-snoring and sleep apnea device available. The TAP® is also the primary oral appliance replacement for the Continuous Positive Airway (CPAP) machine and surgery1.
Dr. Thornton founded Airway Management, Inc. (AMI) in order to market and supply TAP® products both domestically and internationally through dental laboratories. The laboratories purchase parts from AMI and fabricate the device upon the practitioner’s (usually a dentist’s) prescription custom to the patient’s dental casts. The practitioner then fits the patient with the appliance.
Today, TAP® products are sold in the United States, Canada, Europe, Asia, Australia, New Zealand, and South America. Airway Management contributes its great success to the company’s focus on:
• Continuing customer education
• Consistent product research and development
• Personalized customer care
• High quality materials provided by partnering suppliers
• Teamwork and employee excellence
• Compliance with applicable regulatory requirements and
• quality standards as set forth by the Food and Drug
• Administration (FDA), ISO Standards, and Texas Health
• department requirements.
|
1 Pancer J, Al-Faifi S, Al-Faifi M, Hoffstein V. Evaluation of variable mandibular advancement for treatment of snoring and sleep apnea. Chest 1999; 1511-1518; Conaway R, Scherr SC. Multidisciplinary Management of the Airway in a Trauma-Induced Brain Injury Patient. Sleep and Breathing V.8, No.3, 2004: 165-170.
|
